Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of CSL360 in the Treatment of Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, and pharmacokinetics of CSL360 in acute myeloid leukemia. The trial status indicates the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CSL360

Snippet

Sponsor: CSL Limited | Conditions: Acute Myeloid Leukemia (AML) | Phase 1 | Status: COMPLETED